A multivariate analysis showed that FEZF1-AS1 expression is an independent risk factor for the survival of patients with CRC (HR, 2.240; 95% CI, 1.028–4.878; p = 0.042) [49]. This evidence concerns the gene FEZF1 and colorectal carcinoma.